We are live on
!
Find out more
TA
TLS Advisors Portfolio holdings
AUM
$42.1M
1-Year Est. Return
25.99%
This Fund
S&P 500
This Quarter
Est. Return
-17.91%
1 Year Est. Return
+25.99%
3 Year Est. Return
+65.03%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.3M
AUM Growth
–
Cap. Flow
+$25.6M
Cap. Flow
% of AUM
126.12%
Top 10 Holdings %
Top 10 Hldgs %
90.13%
Holding
21
New
21
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQT Corp
EQT
|
+$6.05M |
| 2 |
SI
Silvergate Capital Corporation
SI
|
+$3.17M |
| 3 |
Ovid Therapeutics
OVID
|
+$2.54M |
| 4 |
XOMA
Xoma
XOMA
|
+$2.25M |
| 5 |
OmniAb
OABI
|
+$2.03M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.2% |
| 2 | Energy | 25.89% |
| 3 | Communication Services | 10.32% |
| 4 | Financials | 6.84% |
| 5 | Consumer Discretionary | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
EQT Corp
EQT
$33.8B
| $5.1M | 25.15% |
+150,800
| New | +$6.05M |
|
|
2
Ovid Therapeutics
OVID
$444M
| $2.77M | 13.66% |
+1,490,534
| New | +$2.54M |
|
|
XOMA
3
DELISTED
Xoma
XOMA
| $2.28M | 11.25% |
+124,024
| New | +$2.25M |
|
4
Meta Platforms (Facebook)
META
$1.59T
| $1.76M | 8.65% |
+14,589
| New | +$1.71M |
|
|
5
OmniAb
OABI
$306M
| $1.39M | 6.86% |
+386,592
| New | +$2.03M |
|
|
SI
6
DELISTED
Silvergate Capital Corporation
SI
| $1.39M | 6.84% |
+79,795
| New | +$3.17M |
|
7
Xenon Pharmaceuticals
XENE
$6.4B
| $1.33M | 6.56% |
+33,756
| New | +$1.23M |
|
|
BLU
8
DELISTED
BELLUS Health Inc.
BLU
| $1.03M | 5.1% |
+125,731
| New | +$1.17M |
|
9
Tesla
TSLA
$1.4T
| $739K | 3.64% |
+6,000
| New | +$1.14M |
|
|
LITS
10
Lite Strategy Inc
LITS
$35M
| $490K | 2.42% |
+100,514
| New | +$654K |
|
|
FSTX
11
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $343K | 1.69% |
+54,298
| New | +$301K |
|
|
NBIS
12
Nebius Group N.V.
NBIS
$55.4B
| $337K | 1.66% |
+17,811
| New | +$337K |
|
13
Hovnanian Enterprises
HOV
$771M
| $272K | 1.34% |
+6,472
| New | +$274K |
|
14
iShares MSCI Singapore ETF
EWS
$1.03B
| $255K | 1.26% |
+13,600
| New | +$246K |
|
|
AFMD
15
DELISTED
Affimed
AFMD
| $201K | 0.99% |
+16,197
| New | +$284K |
|
16
Regeneron Pharmaceuticals
REGN
$68.3B
| $180K | 0.89% |
+250
| New | +$184K |
|
17
Nkarta
NKTX
$172M
| $161K | 0.79% |
+26,842
| New | +$271K |
|
18
Range Resources
RRC
$9.06B
| $150K | 0.74% |
+59,823
| New | +$1.64M |
|
|
APTO
19
DELISTED
Aptose Biosciences, Inc.
APTO
| $52K | 0.26% |
+199
| New | +$53.5K |
|
|
NNDM
20
Nano Dimension
NNDM
$312M
| $51K | 0.25% |
+22,000
| New | +$53.5K |
|
|
NIRWW
21
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
| $1K | ﹤0.01% |
+10,000
| New | +$1.05K |
|
Similar funds
ACM
VEPM
SIM
FDG
GC
LSA
VAM
VI
TLS Advisors's Q4 2022 Portfolio in Review
Q4 2022 is the first quarter with a 13F filing on record for TLS Advisors, which disclosed 21 positions worth $20.3M. Its ten largest holdings account for 90% of the portfolio.
Its largest position is EQT Corp: 150,800 shares worth $5.1M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, followed by Energy and Communication Services.
- TLS Advisors's largest Q4 2022 buy was EQT Corp: 150,800 shares worth $5.1M.
- TLS Advisors's ten largest holdings make up 90% of its $20.3M portfolio in Q4 2022.
- TLS Advisors disclosed 21 positions in Q4 2022, its first 13F filing on record.
Based on TLS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.